Your browser doesn't support javascript.
loading
Identification of novel vascular targets in lung cancer.
Zhuang, X; Herbert, J M J; Lodhia, P; Bradford, J; Turner, A M; Newby, P M; Thickett, D; Naidu, U; Blakey, D; Barry, S; Cross, D A E; Bicknell, R.
Affiliation
  • Zhuang X; 1] School of Immunity and Infection, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK [2] School of Cancer Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT,
  • Herbert JM; 1] School of Immunity and Infection, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK [2] Technology Hub Sequencing and Bioinformatics, College of Medical and Dental Sciences, Birmingham B15, UK.
  • Lodhia P; School of Immunity and Infection, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Bradford J; AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK.
  • Turner AM; 1] School of Clinical and Experimental Medicine, University of Birmingham, QEHB Research Laboratories, Mindelsohn Way, Birmingham B15 2WB, UK [2] Birmingham Heartlands Hospital, Bordesley Green, Birmingham B9 5SS, UK.
  • Newby PM; School of Immunity and Infection, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Thickett D; School of Clinical and Experimental Medicine, University of Birmingham, QEHB Research Laboratories, Mindelsohn Way, Birmingham B15 2WB, UK.
  • Naidu U; 1] School of Clinical and Experimental Medicine, University of Birmingham, QEHB Research Laboratories, Mindelsohn Way, Birmingham B15 2WB, UK [2] Birmingham Heartlands Hospital, Bordesley Green, Birmingham B9 5SS, UK.
  • Blakey D; AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK.
  • Barry S; AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK.
  • Cross DA; AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK.
  • Bicknell R; 1] School of Immunity and Infection, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK [2] School of Cancer Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT,
Br J Cancer ; 112(3): 485-94, 2015 Feb 03.
Article in En | MEDLINE | ID: mdl-25535734
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Molecular Targeted Therapy / Lung Neoplasms / Neovascularization, Pathologic Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Molecular Targeted Therapy / Lung Neoplasms / Neovascularization, Pathologic Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2015 Document type: Article